글로벌 파버병 약물 시장 - 업계 동향 및 2028년까지의 예측

Farber's Disease 약물 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 파버병 약물이 2021-2028년 예측 기간 동안 약 6.2%의 CAGR을 보일 것이라고 분석했습니다. 많은 연구 기관과 제약 회사에 기금을 제공하기 위한 정부 정책과 이니셔티브의 증가, 새로운 약물의 등장 증가, 연구 개발 활동에 대한 지출 증가가 파버병 약물 시장 성장에 기여하는 주요 요인입니다.

파버병은 지질 대사의 오류를 특징으로 하는 질병입니다. 파버병은 세라미다아제 결핍으로 인해 발생하는 희귀한 유전성 질환입니다. 세라미다아제는 세포 내 지방을 분해하는 역할을 합니다.

치료에 대한 인식이 높아지고 노령 인구가 늘어나는 것은 파버병 약물 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출이 증가하고 개인의 가처분 소득이 늘어나는 것도 시장 성장을 촉진하고 있습니다. 또한, 생명공학 및 제약 회사의 신약 및 치료법 개발을 위한 연구 개발 활동이 늘어나면서 수익성 있는 시장 성장 기회가 창출될 것입니다. 나쁜 생활 방식과 건강에 해로운 식습관을 받아들이면 파버병 약물 시장 가치가 성장할 것입니다.

그러나 여러 회사의 특허 만료는 시장 성장에 큰 도전이 될 것입니다. 시장에서 제네릭 약물의 가용성은 시장 성장률을 더욱 떨어뜨릴 것입니다. 낮은 유병률로 인한 파버병에 대한 인식 부족은 시장 성장률을 더욱 어렵게 만들 것입니다.   

This farber's disease drug market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on farber's disease drug market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Farber's Disease Drug Market Scope and Market Size

The farber's disease drug market is segmented on the basis of type, treatment type, route of administration, distribution channel and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on the type, the farber's disease drug market has been segmented into classical variant of farber disease, intermediate or mild variant of farber disease, neonatal-visceral variant of farber disease, neurological progressive variant of farber disease, combined farber and sandhoff disease variant and prosaposin deficiency.
• On the basis of treatment type, the farber's disease drug market is segmented into medication and surgery. Medication segment is sub-segmented into corticosteroids. Surgery segment is sub-segmented into bone marrow transplants.
• On the basis of route of administration, the farber's disease drug market is segmented into oral, injectable and others.
• On the basis of distribution channel, the farber's disease drug market is segmented into online pharmacy, direct tenders, retailers and others.
• On the basis of end users, the farber's disease drug market is segmented into hospitals, homecare, specialty clinics and others.

Farber's Disease Drug Market Country Level Analysis

The farber's disease drug market is analysed and market size insights and trends are provided by country, type, treatment type, route of administration, distribution channel and end users as referenced above.

The countries covered in the farber's disease drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the market owing to the prevalence of advanced healthcare infrastructure. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure coupled with growth and expansion of life sciences industry.   

The country section of the farber's disease drug market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Farber's disease drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Farber's Disease Drug Market Share Analysis

The farber's disease drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to farber's disease drug market.

Farber's Disease Drug Market Report에서 다루는 주요 기업은 F. Hoffmann-La Roche Ltd, Novartis AG, Astrazeneca, Pfizer Inc., Sanofi, Johnson & Johnson Services, Inc., AbbVie Inc., Allergan, Merck & Co., Inc., Amgen Inc., DAIICHI SANKYO COMPANY, LIMITED., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., GlaxoSmithKline plc, Cardinal Health, Mylan NV, Boehringer Ingelheim International GmbH, Kowa Pharmaceuticals America, Inc., WOCKHARDT. Incorporated 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-44707